Scilex Holding Rings the Opening Bell

About This Event

Scilex Holding (Nasdaq: SCLX), Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Jaisim Shah, CEO & President, Scilex Holding and Henry Ji, Chairman, President & CEO, Sorrento Therapeutics ring the Opening Bell.